Ken Fisher’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.05M | Sell |
364,745
-141,298
| -28% | -$1.97M | ﹤0.01% | 466 |
|
|
2025
Q4 | $7.1M | Sell |
506,043
-1,175,368
| -70% | -$16.5M | ﹤0.01% | 428 |
|
|
2025
Q3 | $23.5M | Sell |
1,681,411
-338,104
| -17% | -$4.87M | 0.01% | 305 |
|
|
2025
Q2 | $30.4M | Sell |
2,019,515
-522,987
| -21% | -$7.47M | 0.01% | 267 |
|
|
2025
Q1 | $33.5M | Buy |
2,542,502
+73,780
| +3% | +$1.02M | 0.01% | 259 |
|
|
2024
Q4 | $39M | Buy |
2,468,722
+12,207
| +0.5% | +$183K | 0.02% | 251 |
|
|
2024
Q3 | $39M | Buy |
2,456,515
+915,730
| +59% | +$14.7M | 0.02% | 254 |
|
|
2024
Q2 | $23.5M | Sell |
1,540,785
-50,990
| -3% | -$731K | 0.01% | 318 |
|
|
2024
Q1 | $23.4M | Buy |
1,591,775
+565,375
| +55% | +$8.26M | 0.01% | 315 |
|
|
2023
Q4 | $14.3M | Buy |
1,026,400
+573,150
| +126% | +$7.66M | 0.01% | 368 |
|
|
2023
Q3 | $6.06M | Buy |
+453,250
| New | +$6.13M | ﹤0.01% | 494 |
|
|
2018
Q2 | – | Sell |
-25,278,430
| Closed | -$165M | – | 830 |
|
|
2018
Q1 | $165M | Sell |
25,278,430
-1,796,655
| -7% | -$12.6M | 0.22% | 98 |
|
|
2017
Q4 | $203M | Sell |
27,075,085
-266,375
| -1% | -$1.92M | 0.27% | 92 |
|
|
2017
Q3 | $195M | Sell |
27,341,460
-655,710
| -2% | -$4.71M | 0.27% | 89 |
|
|
2017
Q2 | $236M | Buy |
27,997,170
+234,360
| +0.8% | +$1.91M | 0.36% | 79 |
|
|
2017
Q1 | $223M | Sell |
27,762,810
-346,680
| -1% | -$2.99M | 0.36% | 73 |
|
|
2016
Q4 | $255M | Sell |
28,109,490
-375,055
| -1% | -$3.49M | 0.44% | 66 |
|
|
2016
Q3 | $264M | Buy |
28,484,545
+2,349,425
| +9% | +$22.4M | 0.47% | 65 |
|
|
2016
Q2 | $285M | Buy |
26,135,120
+2,258,395
| +9% | +$20.7M | 0.53% | 60 |
|
|
2016
Q1 | $221M | Buy |
23,876,725
+1,351,945
| +6% | +$12.1M | 0.42% | 65 |
|
|
2015
Q4 | $209M | Sell |
22,524,780
-2,282,970
| -9% | -$25M | 0.4% | 65 |
|
|
2015
Q3 | $317M | Sell |
24,807,750
-1,183,520
| -5% | -$14.7M | 0.66% | 52 |
|
|
2015
Q2 | $288M | Sell |
25,991,270
-89,855
| -0.3% | -$992K | 0.56% | 56 |
|
|
2015
Q1 | $298M | Buy |
26,081,125
+5,313,265
| +26% | +$56.4M | 0.6% | 55 |
|
|
2014
Q4 | $210M | Buy |
20,767,860
+793,520
| +4% | +$8.35M | 0.43% | 59 |
|
|
2014
Q3 | $210M | Buy |
19,974,340
+1,108,770
| +6% | +$10.4M | 0.45% | 57 |
|
|
2014
Q2 | $163M | Buy |
18,865,570
+7,251,255
| +62% | +$61M | 0.34% | 62 |
|
|
2014
Q1 | $102M | Buy |
11,614,315
+4,183,700
| +56% | +$36.4M | 0.23% | 72 |
|
|
2013
Q4 | $61M | Buy |
7,430,615
+770,715
| +12% | +$6.1M | 0.14% | 125 |
|
|
2013
Q3 | $50.3M | Buy |
6,659,900
+241,875
| +4% | +$1.76M | 0.12% | 134 |
|
|
2013
Q2 | $48.5M | Buy |
+6,418,025
| New | +$46.9M | 0.13% | 130 |
|
Other funds holding RDY
AIM
Ken Fisher's RDY Position: Q1 2026 in Review
Ken Fisher reduced its Dr. Reddy's Laboratories (RDY) stake by 28% in Q1 2026, selling an estimated $1.97M and leaving 364,745 shares worth $5.05M. The position accounts for ﹤0.01% of the portfolio, ranked #466.
Ken Fisher first reported a position in RDY in Q2 2013 and has held it in 31 quarters since. The position peaked at $317M in Q3 2015. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.
- Ken Fisher held 364,745 shares of Dr. Reddy's Laboratories worth $5.05M as of Q1 2026.
- Ken Fisher sold 141,298 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $1.97M.
- Dr. Reddy's Laboratories made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #466 holding.
- Ken Fisher first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 31 quarters since.
- Ken Fisher's Dr. Reddy's Laboratories position peaked at $317M in Q3 2015.
- 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.